{"schema_version":"secwatch.filing_event.v1","accession":"0001740797-24-000047","form_type":"8-K","ticker":"AVAI","cik":"0001740797","company_name":"AVAI BIO, INC.","filed_at":"2024-09-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.379923+00:00","generated_at":"2026-05-31T05:40:21.897737+00:00","sec_items":["1.02","5.02","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Avant Tech terminates $2.2M Wired4Health asset purchase; CFO replaced","bullets":["APA with Wired4Health for $2.2M consideration cancelled; remaining promissory note balance void.","Payments already made retained by Wired4Health; both parties mutually released from all claims.","CFO William Hisey resigned Sept 9, 2024; COO Vitalis Racius appointed CFO, retains other roles.","No conflicts reported with Hisey's departure."],"urls":{"canonical":"https://secwatch.observer/filing/0001740797-24-000047","json":"https://secwatch.observer/filing/0001740797-24-000047.json","markdown":"https://secwatch.observer/filing/0001740797-24-000047.md","text":"https://secwatch.observer/filing/0001740797-24-000047.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1740797/000174079724000047/0001740797-24-000047-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1740797/000174079724000047/avai_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T05:40:21.897737+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"19710cda12","claim":"William Hisey resigned as Chief Financial Officer at AVAI BIO, INC..","evidence_excerpt":"Effective September 9, 2024, Mr. Hisey vacated his position as Chief Financial Officer (the “CFO”) of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1740797/000174079724000047/0001740797-24-000047-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"ea0724383c","claim":"Vitalis Racius was appointed as Chief Financial Officer at AVAI BIO, INC..","evidence_excerpt":"Mr. Racius, the current Chief Operating Officer (the “COO”), Director, and Treasurer, was reappointed as the Company's Chief Financial Officer (the “CFO”) while continuing his roles as Director and Treasurer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1740797/000174079724000047/0001740797-24-000047-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}